Cancer-Focused Medivir Licenses AMR Centre Promising Superbug Assets

 
• By Sten Stovall
  
Klebsiella
AMRC Will Develop Compounds From Medivir’s Anti-Superbug MBLI Program • Source: Shutterstock

More from Strategy

More from Business